Ann: Clinical Trial Contract Expansion & Increases with Bayer AG, page-3

  1. 412 Posts.
    lightbulb Created with Sketch. 143
    I dont think the revenue is that important but the below statement.


    This further contract amendment and expansion with Bayer continues to validate the
    unique capabilities of our FDA-cleared SphygmoCor® technology. Importantly, it is this
    technology - that is trusted by the leading global pharmaceutical companies - that
    forms the basis of our competitive differentiation as we expand into wearables, smart
    home health devices and other new markets”.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $17.49M
Open High Low Value Volume
4.1¢ 4.1¢ 3.9¢ $2.629K 66.37K

Buyers (Bids)

No. Vol. Price($)
1 50000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 157414 2
View Market Depth
Last trade - 13.42pm 24/06/2025 (20 minute delay) ?
CDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.